BioNano Genomics, Inc. (BNGO) Reports Q4 Net Loss of $29.5M
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Bionano Genomics (BNGO) PT Lowered to $8 at Ladenburg Thalmann
March 2, 2022 7:45 AM ESTLadenburg Thalmann analyst Jeffrey Cohen lowered the price target on Bionano Genomics (NASDAQ: BNGO) to $8.00 (from $9.50) while maintaining a Buy rating following results.
The analyst commented, "Bionano announced Q4- and FY-2021 financial results and held a conference call to discuss. For the... More
